# Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy

> **NCT00209131** · NA · TERMINATED · sponsor: **Emory University** · enrollment: 24 (actual)

## Conditions studied

- Urolithiasis

## Interventions

- **DRUG:** Flomax
- **DRUG:** Sugar pill

## Key facts

- **NCT ID:** NCT00209131
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-04
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Due to frequent turnover of research coordinators and thus poor study accrual.
- **Last updated:** 2013-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209131, "Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00209131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*